How much is Halaven?

How much is Halaven?

The standard cash price of Halaven without health insurance is $9,365 per 6, 2ML of 1MG/2ML Solution though you can save using a SingleCare Halaven coupon to pay just $7,618.42 for 6, 2ML of 1MG/2ML Vial of generic Halaven.

Is Halaven chemotherapy?

Halaven (chemical name: eribulin) is a chemotherapy medicine approved to treat metastatic breast cancer that has already been treated with other chemotherapy medicines. Xeloda (chemical name: capecitabine) is a chemotherapy medicine often used in combination with other anticancer medicines.

How effective is Halaven?

Patients with advanced liposarcoma who were treated with HALAVEN lived an average of 15.6 months compared with patients treated with the other chemotherapy, who lived an average of 8.4 months. This means that patients who received HALAVEN lived 86% longer than patients who received the other chemotherapy.

Is Halaven generic?

Has a generic version of Halaven been approved? No. There is currently no therapeutically equivalent version of Halaven available in the United States.

How does eribulin work?

Eribulin works by stopping the cancer cells from separating into 2 new cells. So it blocks the growth of the cancer. It is a type of drug called a microtubule inhibitor.

What are the side effects of eribulin?

Common side effects of eribulin

  • Effects on the blood. Eribulin can temporarily affect the number of blood cells in the body.
  • Hair loss.
  • Cancer-related fatigue (extreme tiredness)
  • Fertility.
  • Nausea and vomiting.
  • Diarrhoea or constipation.
  • Joint or muscle pain.
  • Headaches.

Do you lose your hair on HALAVEN?

The most common side effects of HALAVEN in adults with breast cancer include low white blood cell count (neutropenia), low red blood cell count (anemia), weakness or tiredness, hair loss (alopecia), nausea, and constipation.

Does eribulin shrink tumors?

Drugs used in chemotherapy, such as eribulin mesylate, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors.

How long can you take eribulin?

This 2-day treatment is given again every 21 days until your body responds to the medicine or you and your doctor decide to stop the treatment. Each treatment usually takes about 2 to 5 minutes.

Does HALAVEN cause hair loss?

How long can you stay on eribulin?

”There was a significant prolongation of survival in the group of women who received eribulin,” he tells WebMD. Those on eribulin lived a median of 13.1 months (half survived longer, half less) compared to a median survival time of 10.6 months for women treated with other therapies.

Is eribulin a chemotherapy?

Eribulin is a chemotherapy drug.

Which is the first generic version of Halaven launched in India?

Emcure Pharmaceuticals, a leading integrated global pharmaceutical company from India has announced the launch of the world’s first generic version of Eisai Pharmaceutical’s Halaven (Eribulin) for the treatment of metastatic breast cancer (MBC).

Is there a generic version of Halaven (Eribulin)?

Eribilin is world’s first generic version of Eisai Pharmaceutical’s Halaven (Eribulin) for the treatment of metastatic breast cancer (MBC). Eribulin is a mechanistically unique inhibitor of microtubule dynamics and binds predominantly to a small number of high affinity sites through both cytotoxic and non-cytotoxic mechanisms.

What is the cost of eribulin treatment in India?

The Emcure pharmaceuticals India company is offering ERIBILIN (Generic Eribulin) at INR 19,000 per vial, One cycle needs around four vials and a full treatment of four cycles would cost roughly INR 3 lakh, while Eisai sells Halaven at INR 31,880 per vial, charging roughly about INR 5 lakh.

What is Halaven used to treat?

Brochure HALAVEN is indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens. read more… read more… read more…